Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osmotic agents for peritoneal dialysis.

R Khanna, Z J Twardowski, D G Oreopoulos

    The International Journal of Artificial Organs
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Twice-daily icodextrin for ultrafiltration failure.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2011
    Same author

    Is professional courtesy dying?

    Canadian Medical Association journal·2010
    Same author

    Know history of CAPD accurately.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2009
    Same author

    Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature.

    Clinical nephrology·2009
    Same author

    Intravenous iron sucrose changes the intraperitoneal homeostasis.

    Blood purification·2009
    Same author

    The effect on renal structure and function of late-life-introduced caloric restriction (CR) in rats.

    International urology and nephrology·2008

    Researchers are exploring alternatives to glucose for peritoneal dialysis solutions. Future dialysis solutions may combine multiple osmotic agents to improve patient outcomes for both short and long exchanges.

    Area of Science:

    • Nephrology
    • Biomaterials Science

    Background:

    • Glucose is the current standard osmotic agent in peritoneal dialysis (PD) solutions.
    • Despite its efficacy, there is ongoing research to find alternative osmotic agents for PD.
    • Existing alternatives like albumin, amino acids, gelatin, and glycerol show limitations for both short and long PD exchanges.

    Purpose of the Study:

    • To evaluate potential alternative osmotic agents for peritoneal dialysis solutions.
    • To identify agents suitable for both short-dwell and long-dwell peritoneal dialysis exchanges.
    • To explore the future development of novel PD solutions.

    Main Methods:

    • Literature review and analysis of existing research on osmotic agents for PD.
    • Evaluation of the efficacy and limitations of glucose, albumin, amino acids, gelatin, and glycerol in PD.

    Related Experiment Videos

  • Predictive analysis of future trends in PD solution development.

    • Main Results:

    • No single alternative agent currently matches glucose's versatility for both short and long PD exchanges.
    • Albumin and amino acids show promise but are limited by high manufacturing costs.
    • Each tested agent demonstrates suitability for either short-dwell or long-dwell exchanges, but not both.

    Conclusions:

    • Future peritoneal dialysis solutions are likely to incorporate a mixture of osmotic agents.
    • Combined osmotic agents could offer efficacy for both short and long exchanges.
    • This approach aims to minimize toxicity and long-term side effects, improving patient care.